These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35545456)

  • 1. The Use of a Viscoelastic-Based Transfusion Algorithm Significantly Reduces Non-red Blood Cell Transfusion in Patients Undergoing Left Ventricular Assist Device Placement or Heart Transplantation: A Single-Center Observational Study.
    Lanigan M; Siers D; Wilkey A; Barakat A; Shaffer A; John R; Knoper R; Huddleston S; Kaizer A; Perry TE
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):3038-3046. PubMed ID: 35545456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adherence to an Intraoperative Blood Product Transfusion Algorithm Is Associated With Reduced Blood Product Transfusions in Cardiac Surgical Patients Undergoing Coronary Artery Bypass Grafts and Aortic and/or Valve Replacement Surgery: A Single-Center, Observational Study.
    Lanigan M; Siers D; Schramski M; Shaffer A; John R; Knoper R; Huddleston S; Gunn-Sandell L; Kaizer A; Perry TE
    J Cardiothorac Vasc Anesth; 2024 May; 38(5):1135-1143. PubMed ID: 38413344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Intraoperative Blood Product Use During Heart Transplantation in Patients Bridged with Impella 5.5 versus Durable Left Ventricular Assist Devices.
    Shapiro AB; Fritz AV; Kiley S; Sharma S; Patel P; Heckman A; Martin AK; Goswami R
    J Cardiothorac Vasc Anesth; 2024 May; ():. PubMed ID: 39003127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboelastography (TEG)-based algorithm reduces blood product utilization in patients undergoing VAD implant.
    Sun W; Jeleniowski K; Zhao X; Shen P; Li D; Hammond JA
    J Card Surg; 2014 Mar; 29(2):238-43. PubMed ID: 24734284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of prothrombin complex concentrate as a warfarin reversal agent in pediatric patients undergoing orthotopic heart transplantation.
    Sisti DJ; Williams GD; Ding V; Long J; Maeda K; Chen S; Navaratnam M
    Paediatr Anaesth; 2020 May; 30(5):564-570. PubMed ID: 32037665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk?
    Williams M; Casher J; Joshi N; Hankinson T; Warren M; Oz M; Naka Y; Mancini D
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):436-41. PubMed ID: 12928641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Readmission and resource utilization after orthotopic heart transplant versus ventricular assist device in the National Readmissions Database, 2010-2014.
    Mukdad L; Mantha A; Aguayo E; Sanaiha Y; Juo YY; Ziaeian B; Shemin RJ; Benharash P
    Surgery; 2018 Aug; 164(2):274-281. PubMed ID: 29885741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors related to transfusion requirements in patients undergoing implantation of ventricular assist devices.
    Neill S; Engoren M; Kouatli Y; Shields TA; Jewell E; Pagani FD
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):297-302. PubMed ID: 25488077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It keeps on turning: Effects of prolonged long-term left ventricular assist device support as a bridge to heart transplantation.
    Schmack B; Grossekettler L; Zeriouh M; Weymann A; Mohite P; Koch A; Ruhparwar A; Simon AR; Sabashnikov A; Popov AF
    Int J Artif Organs; 2019 Feb; 42(2):65-71. PubMed ID: 30580668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Pediatric Ventricular Assist Devices in Children's Hospitals From 2000 to 2010: Morbidity, Mortality, and Hospital Charges.
    Mansfield RT; Lin KY; Zaoutis T; Mott AR; Mohamad Z; Luan X; Kaufman BD; Ravishankar C; Gaynor JW; Shaddy RE; Rossano JW
    Pediatr Crit Care Med; 2015 Jul; 16(6):522-8. PubMed ID: 25850863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation.
    Sun GH; Patel V; Moreno-Duarte I; Zahedi F; Ursprung E; Couper G; Chen FY; Welsby IJ; Comenzo R; Kao G; Cobey FC
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):161-167. PubMed ID: 29198634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally Invasive Left Ventricular Assist Device Insertion Facilitates Subsequent Heart Transplant.
    Rabin J; Ziegler LA; Cipriano S; Madathil RJ; Feller ED; Sorensen EN; Griffith BP; Kaczorowski DJ
    Innovations (Phila); 2021; 16(2):157-162. PubMed ID: 33410713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of bleeding-related morbidity with left ventricular assist device implantation in the current era.
    Krishan K; Nair A; Pinney S; Adams D; Anyanwu AC
    Artif Organs; 2012 Aug; 36(8):746-51. PubMed ID: 22607225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation.
    Gaffey AC; Phillips EC; Howard J; Hung G; Han J; Emery R; Goldberg L; Acker MA; Woo YJ; Atluri P
    Ann Thorac Surg; 2015 Aug; 100(2):542-9. PubMed ID: 26070597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early massive transfusion and blood component ratios in patients undergoing left ventricular assist device implantation.
    Hong Y; Dufendach K; Wang Y; Thoma F; Kilic A
    J Card Surg; 2021 Dec; 36(12):4519-4526. PubMed ID: 34558110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests.
    Coakley M; Reddy K; Mackie I; Mallett S
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):548-53. PubMed ID: 16884987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.